Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Dawei Biological Engineering is a prominent Chinese medical device company specializing in the development and manufacture of in vitro diagnostic (IVD) products. Established in 2001 and headquartered in Qingdao, the company focuses on rapid diagnostic test kits utilizing colloidal gold immunochromatography and lateral flow assay technologies. Their extensive product portfolio includes fertility tests, infectious disease screenings, drug of abuse tests, and tumor marker assays. The company operates under strict quality management systems, holding ISO 13485 certification and CE marking for many of its products. Qingdao Dawei serves a global market, providing point-of-care testing solutions for both professional clinical use and over-the-counter consumer applications. The company is particularly well-known for its "DAVID" brand of pregnancy and ovulation tests, which maintain a significant market share in China and internationally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Dawei Biological Engineering.